Cell Disease Models

PromoCell offers a large selection of cell donors with known disease status suitable for drug discovery and research applications. Our diseased cells feature the same specifications and undergo the same rigid quality control tests as their healthy counterparts from our human primary cell portfolio (marker characterization, growth performance, morphology, etc.). All diseased cell types can be cultured using our matching growth media to ensure optimal growth performance for your experiments.

ra-diabetesDiabetes Type I and II

ra-respiratoryRespiratory Diseases (COPD, Asthma)

ra-cardiovascularCardiomyopathy

Main Advantages

  • All diseased cell types are cryopreserved at the end of the first passage after tissue isolation (with the exception of HCAEC, which are cryopreserved after the second passage)
  • Verified cell identity by cell marker expression and morphology
  • Tested cell growth performance and morphology during several passages for each lot
  • Flexible cell lot/donor reservations

Choose your Region

Please choose your region for an optimized website experience. So we can provide you with the most useful information for your country.

  1. North America
    1. Canada
    2. United States
  2. Europe
    1. Albania
    2. Austria
    3. Belgium
    4. Bosnia-Herzogovina
    5. Bulgaria
    6. Croatia
    7. Czech Republic
    8. Denmark
    9. Estonia
    10. Finland
    11. France
    12. Germany
    13. Greece
    14. Hungary
    15. Ireland
    16. Italy
    17. Latvia
    18. Liechtenstein
    19. Lithuania
    20. Luxembourg
    21. Macedonia
    22. Monaco
    23. Netherlands
    24. Norway
    25. Poland
    26. Portugal
    27. Romania
    28. Serbia
    29. Slovakia
    30. Slovenia
    31. Spain
    32. Sweden
    33. Switzerland
    34. United Kingdom
  3. Asia
    1. Bangladesh
    2. China
    3. Hong Kong (incl. Macau)
    4. India
    5. Indonesia
    6. Israel
    7. Japan
    8. Malaysia
    9. Nepal
    10. Singapore
    11. South Korea
    12. Sri Lanka
    13. Taiwan
    14. Thailand
  4. Oceania
    1. Australia
    2. New Zealand